ArticleCancers2023

A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies.

Lorenzo Manna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.